India to Colombia: Oxaliplatin Export Trade Route

The India to Colombia Oxaliplatin corridor is one of India's established pharmaceutical export routes, with 39 shipments documented worth a combined $1.6M USD. The route is dominated by NAPROD LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's oxaliplatin manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $40.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 26.7%, placing it at rank #16 among India's top oxaliplatin export destinations globally.

On the import side, key buyers of Indian oxaliplatin in Colombia include FRESENIUS KABI COLOMBIA SAS, SEVEN PHARMA COLOMBIA S A S, SEVEN PHARMA COLOMBIA S.A.S and 5 others. FRESENIUS KABI COLOMBIA SAS is the single largest importer with 13 shipments valued at $647.2K USD.

India's oxaliplatin exports to Colombia are driven primarily by a handful of large-scale manufacturers. NAPROD LIFE SCIENCES PRIVATE LIMITED with 18 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Colombia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NAPROD LIFE SCIENCES PRIVATE LIMITED, FRESENIUS KABI ONCOLOGY LIMITED, FRESENIUS KABI ONCOLOGY LIMITED — together account for 96% of total trade value on this route. The average shipment value of $40.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as oxaliseven-100 (oxaliplatin for injection usp 100mg) (16718 vials) and oxaliplatino inj. 100mg/20ml vial, batch, suggesting that buyers in Colombia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FRESENIUS KABI COLOMBIA SAS is the largest importer with 13 shipments worth $647.2K USD — representing 41% of all oxaliplatin imports from India on this route. A total of 8 buyers are active on this corridor.